Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis-Reference-Cited by-同舟云学术

Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis

Published:2021-04-06 Issue:7 Volume:44 Page:1070-1080
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Matsumoto Monica M.,Mouli Samdeep,Saxena Priyali,Gabr Ahmed,Riaz Ahsun,Kulik Laura,Ganger Daniel,Maddur Haripriya,Boike Justin,Flamm Steven,Moore Christopher,Kalyan Aparna,Desai Kush,Thornburg Bartley,Abecassis Michael,Hickey Ryan,Caicedo Juan,Grace Karen,Lewandowski Robert J.,Salem Riad^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00270-021-02810-8.pdf

Reference30 articles.

1. Yu SJ. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol. 2016;22(1):7–17.

2. Benson AB, Dangelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. J Nat Compr Cancer Netw. 2017;15(5):563–73.

3. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.

4. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9.

5. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RP, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–71.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Machine Learning Model Based on Counterfactual Theory for Treatment Decision of Hepatocellular Carcinoma Patients;Journal of Hepatocellular Carcinoma;2024-08

2. Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips;Seminars in Interventional Radiology;2024-02

3. Liver transplantation for HCC in cirrhosis: Are Milan criteria outdated?;Zeitschrift für Gastroenterologie;2024-01

4. Interventional radiology and the liver vasculature: A personal perspective;Clinical Liver Disease;2024-01

5. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma;Frontiers in Immunology;2023-12-19